IP Library Patent Application 18374208
Patent Application
App. No. 18/374,208

CONTACT LENS TREATING SOLUTION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/374,208
Filed
Sep 28, 2023
Art Unit
1761
USPC
510/112
Abstract

A contact lens treating solution includes (a) one or more potassium salts selected from the group consisting of potassium chloride, potassium citrate, potassium hydroxide, potassium borate, potassium ethylenediaminetetraacetic acid and potassium phosphate, (b) an antimicrobial agent comprising alexidine or a salt or a free base thereof, and (c) optionally, one or more sodium salts selected from the group consisting of sodium chloride, sodium citrate, sodium hydroxide, sodium phosphate, sodium ethylenediaminetetraacetic acid and sodium borate, wherein the one or more potassium salts are present in an amount greater than an amount of the one or more sodium salts when present.

Claims (35)

1 . A contact lens treating solution, comprising:

(a) one or more potassium salts selected from the group consisting of potassium chloride, potassium citrate, potassium hydroxide, potassium borate, potassium ethylenediaminetetraacetic acid and potassium phosphate;

(b) an antimicrobial agent comprising alexidine or a salt or a free base thereof; and

(c) optionally, one or more sodium salts selected from the group consisting of sodium sodium citrate, sodium hydroxide, sodium phosphate, sodium chloride, ethylenediaminetetraacetic acid and sodium borate;

wherein the one or more potassium salts are present in an amount greater than an amount of the one or more sodium salts when present.

2 . The contact lens treating solution according to claim 1 , wherein the one or more potassium salts include potassium chloride and the corresponding sodium salt is sodium chloride.

3 . The contact lens treating solution according to claim 1 , wherein the antimicrobial agent comprises alexidine.

4 . The contact lens treating solution according to claim 1 , comprising:

(a) about 0.02 to about 1.5 wt. % of the one or more potassium salts, based on the total weight of the contact lens treating solution; and

(b) about 0.0001 to about 0.0006 wt. % of the antimicrobial agent, based on the total weight of the contact lens treating solution.

5 . The contact lens treating solution according to claim 1 , further comprising one or more additional antimicrobial agents.

6 . The contact lens treating solution according to claim 5 , wherein the one or more additional antimicrobial agents comprise one or more polyquaternium polymers.

7 . The contact lens treating solution according to claim 6 , wherein the one or more polyquaternium polymers comprise from about 30 to about 50,000 quaternary-amine-functional repeating units.

8 . The contact lens treating solution according to claim 6 , wherein the one or more polyquaternium polymers comprise Polyquaternium-1.

9 . The contact lens treating solution according to claim 6 , comprising:

about 0.0001 wt. % to about 0.0003 wt. %, based on the total weight of the contact lens treating solution, of the one or more polyquaternium polymers.

10 . The contact lens treating solution according to claim 5 , wherein the one or more additional antimicrobial agents are selected from the group consisting of a polymeric biguanide or a salt or a free base thereof, a terpene compound, a branched, glycerol monoalkyl ether, a branched, glycerol monoalkyl amine, a branched, glycerol monoalkyl sulphide, a fatty acid monoester, wherein the fatty acid monoester comprises an aliphatic fatty acid portion having six to fourteen carbon atoms and an aliphatic hydroxyl portion, an amidoamine compound, and combinations thereof.

11 . The contact lens treating solution according to claim 10 , wherein the polymeric biguanide or a salt or a free base thereof is a polymeric hexamethylene biguanide.

12 . The contact lens treating solution according to claim 1 , further comprising one or more surfactants.

13 . The contact lens treating solution according to claim 12 , wherein the one or more surfactants are selected from the group consisting of a poloxamer, a poloxamine and mixtures thereof.

14 . The contact lens treating solution according to claim 1 , further comprising one or more comfort agents.

15 . The contact lens treating solution according to claim 14 , wherein the one or more comfort agents are selected from the group consisting of a polyol, an antioxidant and a complex carbohydrate.

16 . The contact lens treating solution according to claim 1 , further comprising one or more polysaccharides.

17 . The contact lens treating solution according to claim 1 , wherein the sodium salt includes one or more of sodium chloride, sodium citrate, and sodium phosphate.

18 . The contact lens treating solution according to claim 1 , in the form of an eye care or a contact lens care product selected from the group consisting of eye drops, a contact lens preservative solution, a contact lens cleaning solution, and a contact lens multi-purpose solution.

19 . A method of cleaning and disinfecting a contact lens, the method comprising soaking the contact lens in one or more contact lens treating solutions for a time period sufficient to clean and disinfect the contact lens, wherein the one or more contact lens treating solutions comprise:

(a) one or more potassium salts selected from the group consisting of potassium chloride, potassium citrate, potassium hydroxide, potassium borate, potassium ethylenediaminetetraacetic acid and potassium phosphate;

(b) an antimicrobial agent comprising alexidine or a salt or a free base thereof; and

(c) optionally, one or more sodium salts selected from the group consisting of sodium sodium citrate, sodium hydroxide, sodium phosphate, sodium chloride, ethylenediaminetetraacetic acid and sodium borate;

wherein the one or more potassium salts are present in an amount greater than an amount of the one or more sodium salts when present.

20 . A method for inhibiting adhesion of bacteria to a surface of a contact lens, the method comprising contacting the surface of the contact lens with one or more contact lens treating solutions comprising:

(a) one or more potassium salts selected from the group consisting of potassium chloride, potassium citrate, potassium hydroxide, potassium borate, potassium ethylenediaminetetraacetic acid and potassium phosphate;

(b) an antimicrobial agent comprising alexidine or a salt or a free base thereof; and

(c) optionally, one or more sodium salts selected from the group consisting of sodium chloride, sodium citrate, sodium hydroxide, sodium phosphate, sodium ethylenediaminetetraacetic acid and sodium borate;

wherein the one or more potassium salts are present in an amount greater than an amount of the one or more sodium salts when present.

Assignments (5)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (065709/0253) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0691 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
SECURITY INTEREST Recorded Feb 12, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066552/0041 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 29, 2023
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 065709/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2023
From: FRIDMAN, KRISTA; BARNIAK, VICKI; DUEX, JOHN MICHAEL; SUPERSAD, ELORA; CULBERTSON, OLIVIA
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065063/0502 →